AGP Limited

AGP

PK0113801010

Pharmaceuticals

End-of-day quote Pakistan S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
80.85 ^PKR	-0.80%		-1.39%	+14.99%

Feb. 29	AGP Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	AGP Limited Announces CEO Changes	CI

AGP Limited Approves Final Cash Dividend for the Year Ended December 31, 2020

February 26, 2021 at 06:05 am EST

AGP Limited announced a final cash dividend for the year ended December 31, 2020 at PKR 1 per share that is 10%.

Latest news about AGP Limited

AGP Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
AGP Limited Announces CEO Changes	Dec. 14	CI
AGP Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-29	CI
AGP Limited Announces Board Changes	23-09-01	CI
AGP Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
AGP Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
AGP Limited (KASE : AGP) completed the acquisition of Portfolio of Products of Viatris Inc.	23-04-07	CI
AGP Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
AGP Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-28	CI
AGP Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-31	CI
AGP Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-31	CI
AGP Limited (KASE : AGP) agreed to acquire Portfolio of Products of Viatris Inc.	22-06-14	CI
AGP Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Norway's Sikri to Buy Geographical Information Technology Consultancy Metria for $77 Million	22-04-01	MT
Flying Nickel Commissions Feasibility Study on Minago Nickel Project in Thompson Nickel Belt, Manitoba	22-03-16	MT
Japan's Osaka Gas enters India's urban gas distribution market	21-12-20	RE
AGP Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-29	CI
AGP Limited acquired Portfolio of 22 Pharmaceutical Products from Sandoz AG.	21-09-16	CI
AGP Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-26	CI
AGP Limited Reports Earnings Results for the First quarter Ended March 31, 2021	21-04-29	CI
Sikri : To Acquire Real Estate Technology Developer For $113.5 Million	21-04-19	MT
AGP Limited Approves Final Cash Dividend for the Year Ended December 31, 2020	21-02-26	CI
Agp Limited Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-26	CI
Agp Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-29	CI
Agp Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-24	CI

AGP Limited is a Pakistan-based pharmaceutical company. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale, and manufacturing of all kinds of pharmaceutical products. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale, and manufacturing of various kinds of pharmaceutical products. It owns a range of products catering to distinct therapeutic needs of the market. It consists of Holding Company's pharmaceutical segment and related products, and OBS AGP's pharmaceutical segment. It offers a diverse portfolio of products in internal medicine, gynecology, pediatrics, nutraceutical, neuropsychiatry, cardiometabolic, hepatology, and orthopedic. Its products include Afdol, Nebcin, Exotan, Nergab, Febuxin, Zerifax, Protege, Maxna, and Rigix, among others. Its subsidiary includes OBS AGP (Private) Limited (OBS AGP). OBS AGP is in the business of trading pharmaceutical products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

80.85 PKR

Average target price

100 PKR

Spread / Average Target

+23.69%

Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AGP LIMITED	+14.99%	81.29M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals

AGP Limited

Equities

AGP

PK0113801010

Pharmaceuticals

AGP Limited Approves Final Cash Dividend for the Year Ended December 31, 2020

Latest news about AGP Limited

Chart AGP Limited

Company Profile

Income Statement Evolution

Analysts' Consensus

Chiffre d''affaires - Rate of surprise

Sector Other Pharmaceuticals